A re-think on site staff competency training required

China |  Opinion | By BioSpectrum Bureau  | 3 Comment | 05 Sep, 2013

When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...Read more

FDA to add 10 new drug inspectors in China

China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2013

Singapore: In an effort to eliminate the weak industry oversight, the US drug regulatory body, the Food and Drug Adminis...Read more

Chinese luring Indian scientists to boost formulation business

China |  News | By BioSpectrum Bureau  | 0 Comment | 02 Sep, 2015

Singapore: In a new trend, Chinese drugmakers have been hiring Indian scientists, with a view to boost the country's for...Read more

Nutrastar marks steady revenue in Q2, 2015

China |  Company results | By BioSpectrum Bureau  | 2 Comment | 14 Aug, 2015

Singapore: China based healthcare product supplier, Nutrastar International, has marked revenue of $13.24 million in thr...Read more

WuXi Healthcare Ventures raises $290M

China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Dec, 2015

WuXi Healthcare Ventures announced the closing of its $290 million WuXi Healthcare Ventures II,exceeding its initial tar...Read more

Is India losing to China in the investment race?

China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

While both India and China - both have a billion plus population - present similar pictures in terms of opportunities an...Read more

WuXi AppTec, Fudan Uni to jointly research on genomics

China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2015

Singapore: China's WuXi AppTec has partnered with Fudan University to bring WuXi NextCODE's population human genomics da...Read more

Start-up landscape in Southeast Asia

China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2015

Singapore: The findings are surprising, mentions BVGH, as often it is the big pharmaceutical companies that invest larg...Read more

Asian firms lack antibody manufacturing capabilities

China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Oct, 2012

There are very few manufacturers in Asia capable of manufacturing antibodies on a large commercial scale. Manufacturing ...Read more

China hep B market to touch $1.4 bn by 2024'

China |  Analysis | By BioSpectrum Bureau  | 2 Comment | 01 Mar, 2016

Singapore: China will remain the largest major hepatitis B market over the next decade, rising from just under $923 mill...Read more

BioSpectrum award winner Biomics uses RNAi for therapeutics

China |  Influencers | By BioSpectrum Bureau  | 2 Comment | 15 Mar, 2013

Biomics Biotechnologies, China, founded in February 2006, is on road to be counted as one of Asia's leading RNA interfer...Read more

Heartbeat Experts expands in BRICK

China |  News | By BioSpectrum Bureau  | 0 Comment | 13 Dec, 2012

Singapore: Heartbeat Experts, the global leader in stakeholder management solutions for the life sciences industry, ann...Read more

Kotaro Yoshida: China, Japan are the new M&A hot spots

China |  Opinion | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

Compared to 2011, global pharmaceutical and biotechnology sectors suffered a setback in the number of mergers and acquis...Read more

Taiwan, China firms to develop novel cancer molecule

China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Oct, 2013

Singapore: Taiwan-based GNT Biotech has got exclusive license from China-based Shenzhen Chipscreen Biosciences for the d...Read more

Dyax, CVie to commercialize Kalbitor in China, HK

China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Feb, 2013

Singapore: Dyax and CVie Therapeutics, a subsidiary of Lee's Pharmaceutical Holdings, announced a strategic partnership...Read more

China: Is this an end to foreign monopoly?

China |  Analysis | By Aishwarya Venkatesh  | 0 Comment | 04 Mar, 2015

Singapore: With 1.3 billion population and a burgeoning middle class, China has witnessed an unprecedented increase in ...Read more

Amgen to open R&D units in Chinese univ

China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Sep, 2013

Singapore: Amgen and ShanghaiTech University, China, entered into a memorandum of understanding (MoU) to form a strategi...Read more

China Health Resource expands its 'Go Global Initiative'

China |  News | By BioSpectrum Bureau  | 0 Comment | 20 Jul, 2012

Singapore: China Health Resource (CHRI) is expanding the company's Go Global Initiative to include the migraine market a...Read more